摘要
目的对在剖宫产70天以内,进行早孕药流和重复药流,实际的效果和安全性等进行研究。方法对在剖宫产以后的239例临床早孕对象进行研究,在这其中在剖宫产后第二次进行药流的早孕对象具有89例,停经的时间一般都在34天到69天之内。先让患者口服米非司酮,服用的方法是(25 mg q12hx5)次,总量是150 mg,首次的计量是50 mg,要求患者在第三天的上午来意愿服用600微克米索前列醇。结果完全流产率达到了92.5%,而不完全流产率则为4.7%,也存在失败率,数值为2.8%。结论得出采用口服米非司酮并且合并使用米索前列醇的方法对于对剖宫产后的早孕现象进行终止,也包括对重复药流患者的早孕终止都有非常有效的作用,在安全性和有效性等方面比较令人满意。并且由于在用药之后,患者的宫颈开始软化,并且宫口也开始扩张,如果药流没有成功,对于吸宫术的执行来说也非常的方便,能够有效的减轻患者的痛苦。
Objective in the cesarean section within 70 days of pregnancy,abortion and repeated abortion,to study the actual effect and safety. Method is to research in cesarean section after 239 cases of clinical pregnancy in 89 cases,with which second postpartum medical abortion in early pregnancy and cesarean section,menopause time is generally 34 to 69 days. Let the patient after mifepristone,taking 25 mg method is q12hx5 times the total 150 mg,for the first time is measured in 50 mg patients on the third day of the morning to intend to take 600 micrograms misoprostol. Results the rate of complete abortion reached 92.5%,while the rate of incomplete abortion was 4.7%,and the failure rate was 2.8%. Conclusion using mifepristone and misoprostol combined with the use of the method for the phenomenon of early pregnancy on postpartum termination,including the repeated medical abortion patients in early pregnancy termination has a very effective role in the safety and effectiveness of other aspects is satisfactory. And due to the medication,patients with cervical softening,and the palace the mouth also began to expand,if not successful for medical abortion,uterine aspiration implementation is also very convenient,but also can effectively alleviate the suffering of patients.
出处
《大医生》
2017年第3期24-25,共2页
Doctor
关键词
米非司酮
米索前列醇
剖宫产
重复药流
mifepristone
misoprostol
cesarean section
repeated abortion